A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

A. Tosco, F. de Gregorio, S. Esposito, D. de Stefano, I. Sana, E. Ferrari, A. Sepe, L. Salvadori, P. Buonpensiero, A. Di Pasqua, R. Grassia, C. A. Leone, S. Guido, G. de Rosa, S. Lusa, G. Bona, G. Stoll, M. C. Maiuri, A. Mehta, G. KroemerL. Maiuri, V. Raia

Research output: Contribution to journalArticle

Original languageEnglish
JournalCell Death and Differentiation
DOIs
Publication statusAccepted/In press - Jul 22 2016

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Tosco, A., de Gregorio, F., Esposito, S., de Stefano, D., Sana, I., Ferrari, E., Sepe, A., Salvadori, L., Buonpensiero, P., Di Pasqua, A., Grassia, R., Leone, C. A., Guido, S., de Rosa, G., Lusa, S., Bona, G., Stoll, G., Maiuri, M. C., Mehta, A., ... Raia, V. (Accepted/In press). A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Cell Death and Differentiation. https://doi.org/10.1038/cdd.2016.43